There are some excellent biotechs on the exchange, there are some with great technology and no cash and others that have bad management. There is an upcoming boom for biotechs IMO.
However, HTX should be avoided as the technology is simply not protected and also there are some big serious questions about the use of biomarker diagnostics.
healthlinx has no intellectual property, page-5
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
